Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Enzo Biochem (NYSE:ENZ) in a research note issued to investors on Sunday morning. The firm issued a hold rating on the medical research company’s stock.

Enzo Biochem Stock Performance

NYSE:ENZ opened at $1.07 on Friday. Enzo Biochem has a 12-month low of $0.93 and a 12-month high of $1.50. The stock’s fifty day simple moving average is $1.11 and its 200-day simple moving average is $1.11.

Enzo Biochem Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 2nd. Stockholders of record on Friday, November 15th were paid a $0.10 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 37.38%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. XTX Topco Ltd raised its position in shares of Enzo Biochem by 94.5% during the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock worth $31,000 after purchasing an additional 13,735 shares during the period. BBR Partners LLC bought a new stake in Enzo Biochem during the 3rd quarter worth approximately $112,000. Geode Capital Management LLC increased its stake in Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after purchasing an additional 11,742 shares in the last quarter. Finally, Renaissance Technologies LLC raised its holdings in Enzo Biochem by 2.6% during the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock worth $2,725,000 after buying an additional 64,417 shares during the period. Institutional investors and hedge funds own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.